Pablo J. Cagnoni's Insider Trades & SAST Disclosures
Pablo J. Cagnoni's most recent trade in Incyte Corp. was a trade of 40,289 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 17, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Pablo J. Cagnoni.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Incyte Corp. | Pablo J. Cagnoni | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 40,289 | 40,289 | - | - | Employee Stock Option (right to buy) | |
| Incyte Corp. | Pablo J. Cagnoni | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 44,411 | 44,411 | - | - | Employee Stock Option (right to buy) | |
| Incyte Corp. | Pablo J. Cagnoni | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 19,851 | 221,919 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Pablo J. Cagnoni | President, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.25 per share. | 15 Jul 2024 | 749 | 221,170 (0%) | 0% | 64.2 | 48,123 | Common Stock |
| Incyte Corp. | Pablo Cagnoni J. | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 21,843 | 21,843 | - | - | Employee Stock Option (right to buy) | |
| Fusion Pharmaceuticals Inc | Pablo J. Cagnoni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 17,000 | 17,000 | - | - | Stock Option (Right to Buy) | |
| Fusion Pharmaceuticals Inc | Pablo J. Cagnoni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 17,000 | 17,000 | - | - | Stock Option (Right to Buy) | |
| Fusion Pharmaceuticals Inc | Pablo J. Cagnoni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges